MITOCHONDRIOCENTRIC PATHWAY TO CARDIOMYOCYTE NECROSIS IN ALDOSTERONISM: CARDIOPROTECTIVE RESPONSES TO CARVEDILOL AND NEBIVOLOL
An evolving schema of the pathophysiologic paradigm contributing to the dyshomeostasis of cardiomyocyte cytosolic free [Ca2+]i and [Ca2+]m as prooxidant, and subsarcolemmal mitochondria and [Zn2+]i and [Zn2+]m, as antioxidant, during chronic aldosteronism is presented, which is accompanied by secondary hyperparathyroidism evoked by ionized hypocalcemia (decreased [Ca2+]o). Elevations in plasma parathyroid hormone (PTH) cause intracellular Ca2+ overloading via L-type Ca2+ channels (LTCC), and the induction of oxidative stress with reactive species (ROS) generation contributing to the opening of the mitochondrial permeability transition pore (mPTP) and ensuing cardiomyocyte necrosis followed by tissue repair and a replacement fibrosis, or myocardial scarring. Antioxidant defenses are mobilized to counteract the prooxidant state. These include: ROS-mediated generation of nitric oxide (NO) from endothelial eNOS, present in both endothelial cells and cardiomyocytes, where NO and its generation of cyclic guanosine monophosphate (cGMP) via guanylyl cyclase (GC) serves to inhibit LTCC. NO also promotes the release of inactive Zn2+ bound to metallothionein (Zn/MT) to raise both [Zn2+]i and [Zn2+]m. The rise in [Zn2+]i activates its sensor, metal-responsive transcription factor (MTF)-1 which, in turn, upregulates transcription of antioxidant defense genes. Zn2+ transporters, induced by ROS, also contribute to increased Zn2+ entry and a resultant rise in [Zn2+]i and [Zn2+]m. In response to catecholamine receptor-ligand binding, β3 adrenergic receptors (β3R) evoke the NO-mediated pathway to Zn2+ release and inhibition of Ca2+ entry via LTCC.